CHEK1 and gastric cancer: This resistance phenotype was consistent across multiple gastric cancer models, including AGS, YCC6, and HGC27 cell lines, and extended beyond ATR inhibition to encompass CHK1 and G2 checkpoint kinase (WEE1) inhibitors, underscoring the critical role of NMD factors in mediating the broader RS response.